Jiazhen Cao

机构：Huashan Hospital · ORCID：0009-0000-8510-5044

发表论文 19 篇 · 总被引 102 次 · h-index 6

代表论文

• Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis (2022 · Frontiers in Immunology · 被引 21)
• ASAP2 interrupts c-MET-CIN85 interaction to sustain HGF/c-MET-induced malignant potentials in hepatocellular carcinoma (2023 · Experimental Hematology and Oncology · 被引 19)
• Clinical Value of Serum and Tissue AGR2 for Diagnosis and Prognosis in Epithelial Ovarian Cancer (2023 · Biomarkers in Medicine · 被引 13)
• A novel CSN5/CRT O-GlcNAc/ER stress regulatory axis in platinum resistance of epithelial ovarian cancer (2024 · International Journal of Biological Sciences · 被引 10)
• TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability (2023 · Cancer Medicine · 被引 9)
• Prognostic significance of pretreatment red blood cell distribution width in primary diffuse large B-cell lymphoma of the central nervous system for 3P medical approaches in multiple cohorts (2022 · The EPMA Journal · 被引 7)